Philip Krause
Fortune : 486 246 $ au 31/08/2026
Fortune : 486 246 $ au 31/08/2026
Dr. Philip R.
Krause is on the Board of Directors at Mesoblast Ltd. Dr. Krause was previously employed as a Deputy Director by US Food & Drug Administration.
He received his undergraduate degree from the University of Illinois, a graduate degree from the University of Illinois, an MBA from Florida State University and a doctorate degree from Yale School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MESOBLAST LIMITED 0,02% | 27/08/2026 | 287 500 ( 0,02% ) | 486 246 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MESOBLAST LIMITED | Directeur/Membre du Conseil | 24/03/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mesoblast Ltd.
Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national